AUCKLAND, NEW ZEALAND / TOKYO, JAPAN – Formus, developer of the world's leading AI-automated 3D pre-operative planning platform, is proud to announce the appointment of Professor Yasuhiro Homma, M.D., Ph.D., as their first Japanese clinical advisor. Prof. Homma’s addition to the advisory team will significantly bolster Formus’s clinical validation and strategic expansion within the Japanese orthopaedic market.
Prof. Homma is a highly esteemed orthopaedic surgeon and researcher, currently serving as the Professor and Department Chair of Orthopaedic Surgery at the Institute of Medicine, University of Tsukuba. Transitioning from a distinguished, long-tenured career at Juntendo University, he also holds prestigious ongoing appointments as an Invited Professor at the Centre National de la Recherche Scientifique (CNRS) in France and a Guest Professor at Juntendo University Hospital.
Homma brings a globally informed perspective to Formus, having completed international fellowships at Cappagh National Orthopaedic Hospital (Ireland), Hôpitaux Universitaires Henri-Mondor (France), and the Cleveland Clinic (USA). Furthermore, he offers invaluable regulatory expertise, having previously served as a Medical Technical Officer specializing in regenerative medicine for Japan's Ministry of Health, Labour and Welfare (MHLW).
"We are thrilled to welcome Prof. Homma to the Formus team," said Ju Zhang, CEO of Formus Labs. "As we activate our rollout across Japan, having an advisor with Prof. Homma's unparalleled clinical foresight and engineering background is a massive strategic advantage. His insights will ensure our platform continues to exceed the rigorous standards of the world's top orthopaedic institutions."
A highly active leader in the Japanese medical community, Prof. Homma is a Board Certified Specialist with the Japanese Orthopaedic Association, and serves as a Councilor for both the Japanese Hip Society and the Japanese Society for Artificial Joints.
His appointment comes at a critical time for Formus Labs as the company accelerates its commercial deployment of Formus Hip and advances its next-generation soft-tissue modelling and image reconstruction capabilities.
.png)
